Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Predictors of glaucoma in patients with uveitis and scleritis



To examine risk factors for development of glaucoma in a large cohort of subjects with uveitis and scleritis.


Retrospective review of subjects diagnosed with uveitis or scleritis between 2006 and 2019 at Auckland District Health Board. Subjects were excluded if they had glaucoma due to another cause. Main outcome measure was development of glaucoma. Data for local steroid use was not available.


3462 eyes of 2414 subjects were included in the study. Mean follow-up was 5.7 years (total follow-up time 19,897 eye years). Median age was 44.3 years and 1189 (49.3%) were female. Glaucoma developed in 222 eyes (6.3%) during the follow-up. Five-year cumulative risk of glaucoma was 6.2% (CI 5.0–7.5%) for anterior uveitis, 5.4% (CI 3.2–9.0%) for intermediate uveitis, 1.6% (CI 0.4–6.7%) for posterior uveitis, 8.7% (CI 6.5–11.7%) for panuveitis, and 3.2% (CI 1.0–9.5%) for scleritis. Five-year cumulative risk of glaucoma was lowest in HLA-B27 uveitis at 0.9% (CI 0.4–2.1%) and highest in viral uveitis 15.1% (CI 10.1–22.3%), sarcoidosis 9.9% (CI 6.1–15.9%) and tuberculosis 9.7% (CI 5.4–17.0%). On multivariate analysis, risk factors for development of glaucoma were older age at presentation, higher presenting intraocular pressure, chronic inflammation, and cystoid macular oedema.


Glaucoma is a common complication of uveitis and scleritis and was more frequent in older subjects, high presenting IOP, chronic inflammation and those with cystoid macular oedema. Local steroid therapy contributes to this, but is not quantifiable in this study. Targeted screening is required to avoid irreversible progression of glaucomatous optic neuropathy.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Cumulative hazard of uveitic glaucoma in eyes with chronic inflammation or acute recurrent inflammation.


  1. Daniel E, Pistilli M, Kothari S, Khachatryan N, Kaçmaz RO, Gangaputra SS, et al. Risk of ocular hypertension in adults with noninfectious uveitis. Ophthalmology. 2017;124:1196–208.

    Article  Google Scholar 

  2. Siddique SS, Suelves AM, Baheti U, Foster CS. Glaucoma and uveitis. Surv Ophthalmol. 2013;58:1–10.

    Article  Google Scholar 

  3. Becker B. Intraocular pressure response to topical corticosteroids. Investig Ophthalmol Vis Sci 1965;4:198–205.

    CAS  Google Scholar 

  4. Betts TD, Sims JL, Bennett SL, Niederer RL. Outcome of peripheral iridotomy in subjects with uveitis. Br J Ophthalmol. 2020;104:8–10.

    Article  Google Scholar 

  5. Neri P, Azuara-Blanco A, Forrester JV. Incidence of glaucoma in patients with uveitis. J Glaucoma. 2004;13:461–5.

    Article  Google Scholar 

  6. Ma T, Sims J, Bennett S, Chew S, Niederer RL. High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis. Br J Ophthalmol. 2021;1–4.

  7. Al-Ani HH, Sims JL, Tomkins-Netzer O, Lightman S, Niederer RL. Vision loss in anterior uveitis. Br J Ophthalmol. 2020;104:1652–7.

  8. Yeo TK, Ho S, Lim W, Teoh S. Causes of visual loss associated with uveitis in a singapore tertiary eye center. Ocul Immunol Inflamm. 2013;21:1652–7.

  9. Tomkins-Netzer O, Talat L, Bar A, Lula A, Taylor SRJ, Joshi L, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. 2014;121:2387–92.

    Article  Google Scholar 

  10. Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–16.

    Article  Google Scholar 

  11. Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M. Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247:137–42.

    CAS  Article  Google Scholar 

  12. Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385:1295–304.

    CAS  Article  Google Scholar 

  13. Moore DB, Jaffe GJ, Asrani S. Retinal nerve fiber layer thickness measurements: uveitis, a major confounding factor. Ophthalmology. 2015;122:511–7.

    Article  Google Scholar 

  14. Bodaghi B, Cassoux N, Wechsler B, Hannouche D, Fardeau C, Papo T, et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine. 2001;80:263–70.

    CAS  Article  Google Scholar 

  15. Heinz C, Koch JM, Zurek-Imhoff B, Heiligenhaus A. Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm. 2009;17:243–8.

    Article  Google Scholar 

  16. Herbert HM, Viswanathan A, Jackson H, Lightman SL. Risk factors for elevated intraocular pressure in uveitis. J Glaucoma. 2004;13:96–9.

    Article  Google Scholar 

  17. Merayo-Lloves J, Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Secondary glaucoma in patients with uveitis. Ophthalmologica. 1999;213:300–4.

    CAS  Article  Google Scholar 

  18. Falcon MG, Williams HP. Herpes simplex kerato-uveitis and glaucoma. Trans Ophthalmol Soc UK. 1978;98:101–4.

    CAS  PubMed  Google Scholar 

  19. Sharon Y, Friling R, Luski M, Campoverde BQ, Amer R, Kramer M. Uveitic glaucoma: long-term clinical outcome and risk factors for progression. Ocul Immunol Inflamm. 2017;25:740–7.

    Article  Google Scholar 

  20. Alvarado J, Murphy C, Polansky J, Juster R. Age-related changes in trabecular meshwork cellularity. Investig Ophthalmol Vis Sci. 1981;21:714–27.

    CAS  Google Scholar 

  21. McMenamin PG, Lee WR, Aitken DAN. Age-related changes in the human outflow apparatus. Ophthalmology. 1986;93:194–209.

    CAS  Article  Google Scholar 

  22. Liu X, Kelly SR, Montesano G, Bryan SR, Barry RJ, Keane PA, et al. Evaluating the impact of uveitis on visual field progression using large-scale real-world data. Am J Ophthalmol. 2019;207:144–50.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations



RN was responsible for study design, data collection, statistical analysis, interpretation and paper writing and review. AW was responsible for analysis, paper writing and review. TM, SC and JS all contributed to collection and review of data and paper review.

Corresponding author

Correspondence to R. L. Niederer.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Niederer, R.L., Wong, A.B.C., Ma, T. et al. Predictors of glaucoma in patients with uveitis and scleritis. Eye (2022).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI:


Quick links